Feed VEEV
VE

Veeva Systems VEEV · NYSE

$310.42 -0.83% (-$2.61)

Market cap
$50.9B
Enterprise value
$49.2B
P/E
50.1x
Forward P/E
33.0x
PEG
2.1x
P/S
14.7x
P/FCF
30.8x
EV/EBITDA
37.9x
ROIC
10.4%
Gross margin
74.9%
Net margin
29.3%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
-1.3x
Beta
0.93
Free float
91.6%

About the company

Veeva Systems Inc. (VEEV) is an American software company specializing in providing cloud-based solutions for the pharmaceutical and biotechnology industries. The company offers integrated platforms for data management, clinical trials, marketing, and collaboration, which help pharmaceutical firms and research institutions improve efficiency and productivity in their processes. With its specialized focus and a wide range of services, Veeva Systems has gained a strong market position and is a preferred partner in the biotechnology sector. Investing in shares of Veeva Systems Inc. (VEEV) can present an interesting opportunity for investors seeking an innovative technology company with a significant presence in the pharmaceutical software domain.

Sector

Technology

Industry

Software - Application

CEO

Peter Gassner

Employees

7,928

Headquarters

Pleasanton

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.